Page 72 - 2018_12-Haematologica-web

G. Kanuri et al.
ings for IDA diagnosis.38 The results of this study are gen- eralizable to women and children from similar agrarian parts of India and possibly to other similar low-middle income settings around the world.
In conclusion, the findings of this study provide a scien- tific rationale for the use of ZPP/H as a POC biomarker to establish the diagnosis of IDA in women and children from low-middle income settings. The diagnostic cut-off values and their accompanying likelihood ratio’s provide clinicians with guidance for using these biomarkers to diagnose IDA.
Acknowledgments
The study samples were a part of a cluster randomized con- trolled trial which was registered with ISRCTN.com (identifier: ISRCTN68413407) on 17 September 2013.
The authors gratefully acknowledge the women and children who participated in the Karnataka Anaemia Project 2 study.
Funding
The study was funded by the Wellcome Trust/DBT India Alliance through a Senior Fellowship Award to Dr. Arun Shet [grant reference number IA/SF/2013/AS/1].
References
1. FAO, IFAD, UNICEF W and W. The state of food security and nutrition in the world. 1-109 p.
2. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva 2011.
3. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Heal Nutr. 2009;12(4):444-454.
4. Who. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Vitamin and Mineral Nutrition Information System. In: Who p1–5.
5. Mwangi MN, Maskey S, Andang o PEA, et al. Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan pregnant women. BMC Med. 2014; 12(1):229.
6. Yu KH. Effectiveness of zinc protopor- phyrin/heme ratio for screening iron defi- ciency in preschool-aged children. Nutr Res Pract. 2011;5(1):40-45.
7. Pasricha S-R, Atkinson SH, Armitage AE, et al. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med. 2014;6 (235):235re3:1-7.
8. Prentice AM, Doherty CP, Abrams SA, et al. Hepcidin is the major predictor of erythro- cyte iron incorporation in anemic African children. Blood. 2012;119(8):1922-1928.
9. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014; 123(5):615-624.
10. Urbaniak GC PS. Research Randomizer v4.0.
11. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352(10):1011- 1023.
12. Camaschella C. Iron-Deficiency Anemia. N Engl J Med. 2015;372(19):1832–1843.
13. Suominen P, Punnonen K, Rajamäki a, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy sub- jects with subclinical iron deficits. Blood. 1998;92(8):2934-2939.
14. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329(7458): 168-169.
15. Soldin OP, Miller M, Soldin SJ. Pediatric ref- erence ranges for zinc protoporphyrin. Clin Biochem. 2003;36(1):21-25.
16. Crowell R, Ferris AM, Wood RJ, Joyce P, Slivka H. Comparative effectiveness of zinc protoporphyrin and hemoglobin concentra- tions in identifying iron deficiency in a group of low-income, preschool-aged chil- dren: practical implications of recent illness. Pediatrics. 2006;118(1):224-232.
17. Abioye AI, Aboud S, Premji Z, et al. Iron supplementation affects hematologic bio- marker concentrations and pregnancy out- comes among iron-deficient Tanzanian women. J Nutr. 2016;146(6):1162-1171.
18. Mohanty D, Mukherjee MB, Colah RB, et al. Iron deficiency anaemia in sickle cell disor- ders in India. Indian J Med Res. 2008; 127(4):366-369.
19. Labbe RF. Clinical utility of zinc protopor- phyrin. Clin Chem. 1992;38(11):2167-2168.
20. Sdogou T, Tsentidis C, Gourgiotis D, et al. Immunoassay-based serum hepcidin refer- ence range measurements in healthy chil- dren : differences among age groups. J Clin Lab Anal. 2015;29(1):10-14.
21. Cangemi G, Pistorio A, Miano M, et al. Diagnostic potential of hepcidin testing in pediatrics. Eur J Haematol. 2013;90(4):323- 330.
22. Bhatia P, Marathe R, Hegde A, Bhardwaj D, Jain R. Plasma hepcidin levels in healthy children from Chandigarh, Northern India. Indian Pediatr. 2017;54(7):599-600.
23. Jaeggi T, Moretti D, Kvalsvig J, et al. Iron sta- tus and systemic inflammation, but not gut inflammation, strongly predict gender-spe- cific concentrations of serum hepcidin in infants in rural Kenya. PLoS One. 2013;8(2):e57513.
24. Mupfudze TG, Stoltzfus RJ, Rukobo S, Moulton LH, Humphrey JH, Prendergast AJ. Hepcidin decreases over the first year of life in healthy African infants. Br J Haematol. 2014;164(1):150-153.
25. Choi HS, Song SH, Lee JH, Kim H-J, Yang HR. Serum hepcidin levels and iron parame- ters in children with iron deficiency. Korean J Hematol. 2012;47286–92.
26. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin Immunoassay for human serum hepcidin. Blood. 2008; 112(10): 4292-4297.
27. Galesloot TE, Vermeulen SH, Geurts- Moespot AJ, et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood. 2011; 117(25): 218-226.
28. Uijterschout L, Swinkels DW, Domellöf M, et al. Serum hepcidin measured by immuno- chemical and mass-spectrometric methods and their correlation with iron status indica- tors in healthy children aged 0.5-3 y. Pediatr Res. 2014;76(4):409-414.
29. van Santen S, van Dongen-Lases EC, de Vegt F, et al. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum. 2011; 63(12):3672-3680.
30. Zimmermann MB, Molinari L, Staubli- Asobayire F, et al. Serum transferrin receptor and zinc protoporphyrin as indicators of iron status in African children. Am J Clin Nutr. 2005;81(3):615-623.
31. Teshome EM, Prentice AM, Demir AY, Andang’o PEA, Verhoef H. Diagnostic utility of zinc protoporphyrin to detect iron defi- ciency in Kenyan preschool children: a com- munity-based survey. BMC Hematol. 2017;17(1):11.
32. Serdar MA, Ümit Sarici S, Kurt I, et al. The role of erythrocyte protoporphyrin in the diagnosis of iron deficiency anemia of chil- dren. J Trop Pediatr. 2000;46(6):323-326.
33. Graham EA, Felgenhauer J, Detter JC, Labbe RF. Elevated zinc protoporphyrin associated with thalassemia trait and hemoglobin E. J Pediatr. 1996;129(1):105-110.
34. Hayden SR, Brown MD. Likelihood ratio: a powerful tool for incorporating the results of a diagnostic test into clinical decisionmak- ing. Ann Emerg Med. 1999;33(5):575-580.
35. McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002;17(8):647-650.
36. Kroot JJC, van Herwaarden AE, Tjalsma H, Jansen RTP, Hendriks JCM, Swinkels DW. Second round robin for plasma hepcidin methods: First steps toward harmonization. Am J Hemato.l 2012;87(10):977-983.
37. WHO. Iron deficiency anaemia: assessment, prevention, and control. A guide for pro- gramme managers. World Heal Organ. 2001;114.
38. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and,accurate reporting of studies of diagnostic accuracy: the STARD initiative. Br Med J. 2003; 326(7379):41-44.
1996
haematologica | 2018; 103(12)